The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease

T. L. Lenz; D. E. Hilleman

The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease

Research output: Contribution to journal › Review article › peer-review

Abstract

This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).

Original language	English (US)
Pages (from-to)	561-562+565
Journal	P and T
Volume	26
Issue number	11
State	Published - Jan 1 2001

All Science Journal Classification (ASJC) codes

Pharmacology (medical)

Cite this

@article{63809ed02d2a4914aae18f5211c2f273,

title = "The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease",

abstract = "This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).",

author = "Lenz, {T. L.} and Hilleman, {D. E.}",

year = "2001",

month = jan,

day = "1",

language = "English (US)",

volume = "26",

pages = "561--562+565",

journal = "Hospital Therapy",

issn = "1052-1372",

publisher = "MediMedia USA Inc.",

number = "11",

}

TY - JOUR

T1 - The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease

AU - Lenz, T. L.

AU - Hilleman, D. E.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).

AB - This review examines the use of combinations of oral antiplatelet agents with oral anticoagulant agents for long-term secondary prevention in patients with cardiovascular diseases such as myocardial infarction (MI), mechanical valve replacement, coronary artery stent implantation, and chronic atrial fibrillation (AF).

UR - http://www.scopus.com/inward/record.url?scp=0035188477&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035188477&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0035188477

SN - 1052-1372

VL - 26

SP - 561-562+565

JO - Hospital Therapy

JF - Hospital Therapy

IS - 11

ER -

The role of combination therapy with antiplatelet and oral anticoagulant agents in cardiovascular disease

Abstract

All Science Journal Classification (ASJC) codes

Other files and links

Fingerprint

Cite this